News

AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...
Targeted Oncology5h
TROP-2 Inhibitors Are Explored in Breast Cancer
Discover the latest advancements in breast cancer treatment at the 24th Annual International Congress, featuring expert insights and groundbreaking research.
Salesforce (CRM) Expands PayPal Integration with Agentforce Platform Upgrade
Salesforce, Inc. (NYSE:CRM) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced an ...